FAIR VALUE MEASUREMENT - Narrative (Details) $ / shares in Units, $ / shares in Units, $ in Thousands, $ in Millions		12 Months Ended
	Mar. 02, 2021 USD ($)	Dec. 31, 2025 USD ($) derivative shares	Dec. 31, 2024 USD ($) shares	Dec. 31, 2021 USD ($)	Dec. 31, 2025 $ / shares	Apr. 06, 2023 $ / shares shares	Nov. 30, 2022 CAD ($) $ / shares	Nov. 14, 2022 USD ($)	Nov. 14, 2022 CAD ($) $ / shares
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Change in fair value of financial instruments		$ (7,269)	$ 615
Investment in unconsolidated entity		$ 8,800	10,800
Number of embedded derivatives | derivative		2
Debt conversion option		$ 5,187	786
Derivative Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]		Derivative and other long-term liabilities
Purchase option	$ 8,000			$ 8,000
Purchase option, term				5 years
Purchase option, extension term				2 years
Percentage of outstanding shares (as a percent)				10.00%
Warrants expiration period				60 days
Loss on change in fair value of purchase option		$ 52	1,678
Debt Conversion Option
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) on hedging instruments		(4,352)	2,265
Debt conversion option		5,187	786
Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment in unconsolidated entity		8,800	10,800
Debt conversion option		0	0
Debt Interest Rate Conversion Feature
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Unrealized gain (loss) on hedging instruments		(865)	228
Debt Interest Rate Conversion Feature | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		$ 211	1,023
Derivative Asset, Statement of Financial Position [Extensible Enumeration]		Derivative and other long-term assets
Stanley Brothers USA Holdings purchase option
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		$ 0	52
Stanley Brothers USA Holdings purchase option | Level 3
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Derivative asset		0	52
BAT Group | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accrued interest rate (as a percent)							1.50%	1.50%	1.50%
BAT Group | Convertible Notes Payable
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Principal amount		$ 63,944	$ 58,172				$ 75.3	$ 56,800	$ 75.3
Convertible, ownership percentage of shares (as a percent)		19.90%					19.90%	19.90%	19.90%
Conversion price (in cad per share) | $ / shares					$ 2.00		$ 2.00		$ 2.00
BAT Group | Convertible Notes Payable | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Accrued interest rate (as a percent)							5.00%	5.00%	5.00%
DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership (as a percent)		50.00%
British American Tobacco | DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units ownership (as a percent)		100.00%
AJNA Biosciences | DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Equity method ownership (as a percent)		50.00%
DeFloria, LLC
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Warrants outstanding (in shares) | shares		4,000,000	400,000
Stock split, conversion ratio		0.1
Change in fair value of financial instruments		$ (2,000)	$ (200)
Investment in unconsolidated entity		$ 8,800	$ 10,800
DeFloria, LLC | Common Class A
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Class of warrant or right, number of securities called by warrants or rights (in shares) | shares						865,052
Warrants exercise price (in cad or usd per share) | $ / shares						$ 2.89
DeFloria, LLC | British American Tobacco
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Preferred units (in shares) | shares		2,000,000	200,000
Capital contributed		$ 10,000
Payment for convertible debt		5,000
DeFloria, LLC | AJNA Biosciences
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Payment for convertible debt		$ 2,000
Warrants outstanding (in shares) | shares		4,000,000	400,000